Mr. John C. Moore serves as Chief Technical Officer of TearSolutions, LLC. Mr. Moore has more than 30 years of executive experience at several ophthalmic medical device companies, where he successfully managed; R&D, operations, marketing, sales, business development, service and finance teams. He served as the Chief Executive Officer and President of Notal Vision, Ltd., an Israeli-based company that developed comprehensive diagnostic solutions for the early detection and monitoring of age-related macular degeneration (AMD) from April 2005 to January 2007. Mr. Moore served as President and Chief Executive Officer of Laser Diagnostic Technologies, a manufacturer of diagnostic laser scanning ophthalmoscopes used for the early detection of glaucoma, which was acquired by Carl Zeiss Meditec, Inc. in 2004. Prior to, he served as Vice President at Alcon Laboratories where he was responsible for pursuing and executing strategic acquisitions and partnerships to broaden its product portfolio. He identified and executed the acquisition of Humphrey Instruments, a manufacturer of ophthalmic diagnostic instruments and subsequently served as the division's President and Chief Executive Officer. Prior to this, Mr. Moore served as Vice President and General Manager at Carl Zeiss Medical, a division of Carl Zeiss, Inc. He spent more than 10 years at Carl Zeiss, Inc., a $2 billion multinational company with primary businesses in optics, medical, scientific and semiconductor products. He began his career in ophthalmic medical devices at Coherent Inc., a laser manufacturer for the industrial, medical and scientific industries. Mr. Moore has been an Independent Director of STAAR Surgical Company since January 2008. He serves on the Boards of Directors of Optovue, a pioneering maker of optical coherence tomography (OCT) imaging tools and Notal Vision, Ltd. He served on the Boards of two ophthalmic industry groups, the Glaucoma Foundation and the Blindness Prevention of America. Mr. Moore holds his Bachelor of Science Degree in General Science from the University of Rochester. Mr. John C. Moore serves as Chief Technical Officer of TearSolutions, LLC. Mr. Moore has more than 30 years of executive experience at several ophthalmic medical device companies, where he successfully managed; R&D, operations, marketing, sales, business development, service and finance teams. He served as the Chief Executive Officer and President of Notal Vision, Ltd., an Israeli-based company that developed comprehensive diagnostic solutions for the early detection and monitoring of age-related macular degeneration (AMD) from April 2005 to January 2007. Mr. Moore served as President and Chief Executive Officer of Laser Diagnostic Technologies, a manufacturer of diagnostic laser scanning ophthalmoscopes used for the early detection of glaucoma, which was acquired by Carl Zeiss Meditec, Inc. in 2004. Prior to, he served as Vice President at Alcon Laboratories where he was responsible for pursuing and executing strategic acquisitions and partnerships to broaden its product portfolio. He identified and executed the acquisition of Humphrey Instruments, a manufacturer of ophthalmic diagnostic instruments and subsequently served as the division's President and Chief Executive Officer. Prior to this, Mr. Moore served as Vice President and General Manager at Carl Zeiss Medical, a division of Carl Zeiss, Inc. He spent more than 10 years at Carl Zeiss, Inc., a $2 billion multinational company with primary businesses in optics, medical, scientific and semiconductor products. He began his career in ophthalmic medical devices at Coherent Inc., a laser manufacturer for the industrial, medical and scientific industries. Mr. Moore has been an Independent Director of STAAR Surgical Company since January 2008. He serves on the Boards of Directors of Optovue, a pioneering maker of optical coherence tomography (OCT) imaging tools and Notal Vision, Ltd. He served on the Boards of two ophthalmic industry groups, the Glaucoma Foundation and the Blindness Prevention of America. Mr. Moore holds his Bachelor of Science Degree in General Science from the University of Rochester.

 Eye Diseases and Disorders